Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PHLDA1 |
| Upstream (Parents) |
|---|
| (<<) FSCN1 → PHLDA1 |
| (<<) NAAA → PHLDA1 |
| (<<) ACSF2 → PHLDA1 |
| (<<) DUSP4 → PHLDA1 |
| (<<) PPP1R9A → PHLDA1 |
| Downstream (Children) |
|---|
| PHLDA1 → MAPK8IP1 (>>) |
| PHLDA1 → TNFRSF11B (>>) |
| PHLDA1 → NENF (>>) |
| PHLDA1 → GAP43 (>>) |
| PHLDA1 → LCE2B (>>) |
| PHLDA1 → PPP1R9A (>>) |
| PHLDA1 → C14orf56 (>>) |
| PHLDA1 → TP53 (>>) |
| PHLDA1 → C9orf31 (>>) |
| PHLDA1 → HTR5A (>>) |
| PHLDA1 → FABP3 (>>) |
| PHLDA1 → FAM169A (>>) |
| PHLDA1 → APLP1 (>>) |
